Do you have the same question? Follow this Question
Feb 02, 2026 - 01:09 PM
We’ve provided several answers to questions related to Taltz (Ixekizumab) , see some other helpful Q&A related to this product.
Question: What conditions is this medication used to treat?
Answer: This medication is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. These are chronic autoimmune diseases, and effective treatment can help manage symptoms and prevent disease progression.
Question: How does this medication work?
Answer: This medication works by binding to interleukin 17A (IL-17A) and neutralizing it, which helps reduce symptoms of inflammation. Interleukin 17A is a protein involved in immune responses, and its inhibition can help control autoimmune disease activity.
Question: What is the MedlinePlus code for this medication?
Answer: The MedlinePlus code is a616025. MedlinePlus provides reliable health information for patients and caregivers.
Question: What is the DrugBank identifier for this medication?
Answer: The DrugBank identifier is DB11569. DrugBank is a resource for detailed drug information, useful for healthcare professionals and researchers.
Question: What are the available brand names for this medication?
Answer: The available brand name is Taltz. Brand recognition can help ensure you receive the correct medication and can make it easier to discuss with your healthcare provider.
Question: What is the elimination half-life of this medication?
Answer: The elimination half-life is 13 days. A longer half-life means the drug remains active in the body for an extended period, allowing for less frequent dosing.
Question: What is the chemical formula of this medication?
Answer: The chemical formula is C6492H10012N1728O2028S46. This complex formula reflects the large, protein-based nature of monoclonal antibodies, allowing them to specifically target immune pathways.
